Watching for answer!
$Tiziana Life Sciences(TLSA.US$ Tiziana Life Sciences: Files for Orphan Drug Designation for Intranasal Foralumab to Treat Non-Active Secondary Progressive Multiple Sclerosis
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
